Cariprazine demonstrates significant efficacy in treating symptoms of major depressive disorder, and is generally well-tolerated.
A systematic review assessed multiple studies to evaluate the efficacy and safety of cariprazine, showing promising results in reducing depressive symptoms.
The review highlighted adverse events associated with cariprazine, indicating a manageable safety profile compared to other treatments.
Findings suggest that cariprazine might be a beneficial option for treating major depressive disorder, warranting further research for comprehensive endorsement.